Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
MaxLinear
MXL
$6.06B
| $489K | ﹤0.01% |
14,391
-14,391
| -50% | -$488K |
|
1727
United Parks & Resorts
PRKS
$2.1B
| $487K | ﹤0.01% |
9,109
-11,507
| -56% | -$616K |
|
1728
RELX
RELX
$61.8B
| $485K | ﹤0.01% |
17,509
-17,287
| -50% | -$465K |
|
1729
Asana
ASAN
$1.92B
| $485K | ﹤0.01% |
35,181
+5,939
| +20% | +$108K |
|
1730
Stepan Co
SCL
$1.46B
| $483K | ﹤0.01% |
4,545
+829
| +22% | +$86.9K |
|
|
PRPC
1731
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $483K | ﹤0.01% |
47,786
-47,786
| -50% | -$479K |
|
|
ORGN
1732
DELISTED
Origin Materials
ORGN
| $482K | ﹤0.01% |
3,486
-5,961
| -63% | -$949K |
|
1733
Broadstone Net Lease
BNL
$4.11B
| $482K | ﹤0.01% |
29,730
-29,728
| -50% | -$497K |
|
1734
Cal-Maine
CALM
$4.12B
| $481K | ﹤0.01% |
8,832
+1
| +0% | +$58 |
|
|
NOVA
1735
DELISTED
Sunnova Energy
NOVA
| $480K | ﹤0.01% |
26,657
-24,479
| -48% | -$493K |
|
1736
California Resources
CRC
$4.67B
| $478K | ﹤0.01% |
10,989
+2,299
| +26% | +$101K |
|
|
MPT
1737
Medical Properties Trust
MPT
$2.77B
| $477K | ﹤0.01% |
42,808
-42,810
| -50% | -$498K |
|
1738
Simmons First National
SFNC
$3.41B
| $476K | ﹤0.01% |
22,076
-22,078
| -50% | -$501K |
|
1739
First Bancorp
FBP
$4.42B
| $473K | ﹤0.01% |
37,238
-37,238
| -50% | -$543K |
|
|
GAP
1740
The Gap Inc
GAP
$7.23B
| $470K | ﹤0.01% |
41,651
-23,859
| -36% | -$285K |
|
1741
ESCO Technologies
ESE
$8.17B
| $469K | ﹤0.01% |
5,357
+1,272
| +31% | +$110K |
|
|
NARI
1742
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $468K | ﹤0.01% |
7,372
| – | – |
|
1743
NETSCOUT
NTCT
$2.96B
| $468K | ﹤0.01% |
14,407
-10,407
| -42% | -$359K |
|
1744
Unilever
UL
$137B
| $465K | ﹤0.01% |
8,213
+303
| +4% | +$16.2K |
|
1745
Macerich
MAC
$7.33B
| $465K | ﹤0.01% |
41,334
-41,332
| -50% | -$467K |
|
1746
Pathward Financial
CASH
$1.86B
| $464K | ﹤0.01% |
10,781
-12,609
| -54% | -$517K |
|
|
RMGC
1747
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $464K | ﹤0.01% |
45,982
-45,986
| -50% | -$460K |
|
1748
Graham Holdings Company
GHC
$5.1B
| $463K | ﹤0.01% |
765
+148
| +24% | +$90.2K |
|
1749
Progress Software
PRGS
$1.66B
| $463K | ﹤0.01% |
9,174
+2,400
| +35% | +$120K |
|
1750
Extreme Networks
EXTR
$3.94B
| $461K | ﹤0.01% |
25,180
-25,182
| -50% | -$441K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.